{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:22:32Z","timestamp":1782231752162,"version":"3.54.5"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> To evaluate the use of the ketogenic diet (KD) for treatment of super-refractory status epilepticus (SRSE) at a pediatric intensive care unit (PICU).<\/jats:p><jats:p><jats:bold>Design:<\/jats:bold> A retrospective analysis of all pediatric patients treated for SRSE with the KD at our center was performed using patient data from our prospective longitudinal KD database.<\/jats:p><jats:p><jats:bold>Setting:<\/jats:bold> SRSE is defined as refractory SE that continues or recurs 24 h or more after initiation of anesthetic drugs. We describe the clinical and electroencephalographic (EEG) findings of all children treated with KD at our PICU. The KD was administered as add-on after failure of standard treatment. Response was defined as EEG seizure resolution (absence of seizures and suppression\u2013burst ratio \u226550%).<\/jats:p><jats:p><jats:bold>Patients:<\/jats:bold> Eight consecutive SRSE patients (four females) treated with KD were included. Median age at onset of SRSE was 13.6 months (IQR 0.9\u2013105), and median age at KD initiation was 13.7 months (IQR 1.9 months to 8.9 years). Etiology was known in 6\/8 (75%): genetic in 4 (50%), structural in 1 (12.5%), and autoimmune\/inflammatory in 1 (12.5%).<\/jats:p><jats:p><jats:bold>Main Results:<\/jats:bold> Time from onset of SRSE to initiation of KD was median 6 days (IQR 1.3\u20139). Time until clinically relevant ketosis (beta-hydroxybutyrate (BHB) &amp;gt;2 mmol\/L in serum) was median 68.0 h (IQR 27.3\u2013220.5). Higher ketosis was achieved when a higher proportion of enteral feeds was possible. Four (50%) patients responded to KD treatment within 7 days. During follow-up (median 4.2 months, IQR 1.6\u201312.3), 5\/8 patients\u2014three of them responders\u2014died within 3\u201312 months after SRSE.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> In eight patients with SRSE due to severe etiologies including Alpers syndrome, we report an initial 50% response to KD. KD was used early in SRSE and sufficient levels of ketosis were reached early in most patients. Higher ketosis was achieved with combined enteral and parenteral feedings.<\/jats:p>","DOI":"10.3389\/fneur.2021.669296","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T17:55:14Z","timestamp":1622742914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Ketogenic Diet in the Treatment of Super-Refractory Status Epilepticus at a Pediatric Intensive Care Unit: A Single-Center Experience"],"prefix":"10.3389","volume":"12","author":[{"given":"Markus","family":"Breu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"H\u00e4fele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Glatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Trimmel-Schwahofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Golej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Male","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0404.2007.00805.x","article-title":"Childhood convulsive status epilepticus: epidemiology, management and outcome","volume":"115","author":"Neville","year":"2007","journal-title":"Acta Neurol Scand."},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1742-6723.2006.00807.x","article-title":"When benzodiazepines fail: how effective is second line therapy for status epilepticus in children?","volume":"18","author":"Lewena","year":"2006","journal-title":"Emerg Med Australas."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology."},{"key":"B4","first-page":"24","article-title":"Refractory convulsive status epilepticus in children: etiology, associated risk factors and outcome","volume":"9","author":"Barzegar","year":"2015","journal-title":"Iran J Child Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.eplepsyres.2014.08.010","article-title":"Determinants and predictors of outcome in super refractory status epilepticus\u2013a developing country perspective","volume":"108","author":"Jayalakshmi","year":"2014","journal-title":"Epilepsy Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"Novy","year":"2010","journal-title":"Epilepsia."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/brain\/aws091","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Ferlisi","year":"2012","journal-title":"Brain."},{"key":"B8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ejpn.2015.05.007","article-title":"Etiology, clinical course and response to the treatment of status epilepticus in children: a 16-year single-center experience based on 602 episodes of status epilepticus","volume":"19","author":"Kravljanac","year":"2015","journal-title":"Eur J Paediatr Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain."},{"key":"B11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","article-title":"Incidence and mortality of super-refractory status epilepticus in adults","volume":"49","author":"Kantanen","year":"2015","journal-title":"Epilepsy Behav."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1046\/j.1528-1157.2001.21301.x","article-title":"Outcome of severe refractory status epilepticus in children","volume":"42","author":"Sahin","year":"2001","journal-title":"Epilepsia."},{"key":"B13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/MOP.0000000000000149","article-title":"Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus","volume":"26","author":"Tasker","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1517\/14656566.2016.1127354","article-title":"Pharmacologic treatment of status epilepticus","volume":"17","author":"Trinka","year":"2016","journal-title":"Expert Opinion Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1542\/peds.105.4.e46","article-title":"Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy","volume":"105","author":"Lefevre","year":"2000","journal-title":"Pediatrics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1528-1157.2003.57002.x","article-title":"The ketogenic diet: adolescents can do it, too","volume":"44","author":"Mady","year":"2003","journal-title":"Epilepsia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","article-title":"The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial","volume":"7","author":"Neal","year":"2008","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","article-title":"Metabolic control of vesicular glutamate transport and release","volume":"68","author":"Juge","year":"2010","journal-title":"Neuron."},{"key":"B19","doi-asserted-by":"publisher","first-page":"35476","DOI":"10.1371\/journal.pone.0035476","article-title":"Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/157015909789152164","article-title":"Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity","volume":"7","author":"Masino","year":"2009","journal-title":"Curr Neuropharm."},{"key":"B21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.seizure.2016.07.006","article-title":"Ketogenic diet treatment for pediatric super-refractory status epilepticus","volume":"41","author":"Appavu","year":"2016","journal-title":"Seizure."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.04.012","article-title":"Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus","volume":"144","author":"Arya","year":"2018","journal-title":"Epilepsy Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.eplepsyres.2014.09.033","article-title":"Ketogenic diet in pediatric patients with refractory focal status epilepticus","volume":"108","author":"Caraballo","year":"2014","journal-title":"Epilepsy Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1111\/j.1528-1167.2010.02703.x","article-title":"Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES)","volume":"51","author":"Nabbout","year":"2010","journal-title":"Epilepsia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1111\/j.1528-1167.2011.03289.x","article-title":"The role of ketogenic diet in the treatment of refractory status epilepticus","volume":"52","author":"Nam","year":"2011","journal-title":"Epilepsia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bj.2020.02.002","article-title":"Application of ketogenic diets for pediatric neurocritical care","volume":"43","author":"Lin","year":"2020","journal-title":"Biomed J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1212\/WNL.0000000000003690","article-title":"Phase I\/II multicenter ketogenic diet study for adult superrefractory status epilepticus","volume":"88","author":"Cervenka","year":"2017","journal-title":"Neurology."},{"key":"B29","first-page":"60","article-title":"Ketogenic diet in status epilepticus","volume-title":"Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease","author":"Nabbout","year":"2016"},{"key":"B30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure."},{"key":"B31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1528-1167.2008.01765.x","article-title":"Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group","author":"Kossoff","year":""},{"key":"B32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia open."},{"key":"B33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia."},{"key":"B34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/epi4.12084","article-title":"Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy","volume":"3","author":"Dressler","year":"2018","journal-title":"Epilepsia Open."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/01.mpg.0000181841.07090.f4","article-title":"Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR)","volume":"41","author":"Koletzko","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/0883073819831179","article-title":"A proof-of-principle, case-control study to compensate for potential carbohydrates in liquid antiseizure drugs in children on the ketogenic diet","volume":"34","author":"Haney","year":"2019","journal-title":"J Child Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.seizure.2010.06.006","article-title":"Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy-the austrian experience","volume":"19","author":"Dressler","year":"2010","journal-title":"Seizure."},{"key":"B38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.eplepsyres.2015.06.015","article-title":"The ketogenic diet in infants - advantages of early use","volume":"116","author":"Dressler","year":"2015","journal-title":"Epilepsy Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-2004-820992","article-title":"Fatal propofol infusion syndrome in association with ketogenic diet","volume":"35","author":"Baumeister","year":"2004","journal-title":"Neuropediatrics."},{"key":"B40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/dmcn.14306","article-title":"Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide","volume":"62","author":"van der Louw","year":"2020","journal-title":"Dev Med Child Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/088307389000500402","article-title":"Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher Syndrome): a personal review","volume":"5","author":"Harding","year":"1990","journal-title":"J Child Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s12028-018-0653-2","article-title":"The feasibility, safety and effectiveness of a ketogenic diet for refractory status epilepticus in adults in the intensive care unit","volume":"30","author":"Francis","year":"2019","journal-title":"Neurocrit Care."},{"key":"B43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2013.07.020","article-title":"The ketogenic diet for the treatment of pediatric status epilepticus","volume":"50","author":"O'Connor","year":"2014","journal-title":"Pediatr Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.669296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T17:55:19Z","timestamp":1622742919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.669296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":43,"alternative-id":["10.3389\/fneur.2021.669296"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.669296","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"article-number":"669296"}}